Skip to main content
BIOTECH logo

BIOTECH — Investor Relations & Filings

Ticker · BST ISIN · ES0184980003 LEI · 959800GNYT6ZZEWPEW29 BME Growth Professional, scientific and technical activities
Open in API
Filings indexed 2,317 across all filing types
Latest filing 2015-06-24 Net Asset Value
Country ES Spain
Listing BME Growth BST

About BIOTECH

https://asebio.com/en/members/directory…

Biotechnology Assets Biat Group is a biotechnology corporate group with a global commercial structure operating through several subsidiaries. Its subsidiary Biobide is a provider of preclinical services, specializing in tailor-made toxicity and efficacy testing using the zebrafish (ZF) animal model. ZIP Solutions develops and promotes a proprietary set of inteins for high-value industrial applications, including gene therapy, immunotherapy, in-vitro diagnostics, smart vaccines (RNA & DNA), and affinity-based protein purification. The Bionatur division manages biotech assets for human and animal health. The group focuses on licensing its platforms and products, conducting preclinical research, and improving recombinant and DNA vaccines through collaborations.

Recent filings

Filing Released Lang Actions
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (June 23, 2015). The content focuses entirely on reporting the NAV per share (880.31p) and details regarding treasury shares, which aligns perfectly with the definition for Net Asset Value updates, primarily associated with investment funds. This matches the 'Net Asset Value (Code: NAV)' category.
2015-06-24 English
THE BIOTECH GROWTH TRUST PLC - Monthly Fact Sheet as at 31 May 2015
Report Publication Announcement Classification · 1% confidence The document text is very short (843 characters) and explicitly states that the 'Monthly Fact Sheet as at 31 May 2015' has been submitted to the National Storage Mechanism and will shortly be available for inspection. This structure—announcing the publication of a document rather than containing the full document content—fits the definition of a Report Publication Announcement (RPA). The document title itself, 'Monthly Fact Sheet', aligns closely with the 'Fund Information / Factsheet' (FS) definition, but the *action* described is the announcement of its availability, making RPA the most accurate classification based on the 'MENU VS MEAL' rule.
2015-06-23 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (June 22, 2015). This directly matches the definition for Net Asset Value updates (NAV). The document is short and contains the core NAV figure, confirming it is the actual update, not an announcement of one.
2015-06-23 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC'. It details the estimated un-audited net asset value per share as of a specific date (June 19, 2015) and mentions treasury shares. This content directly matches the definition for Net Asset Value updates, which corresponds to the filing code NAV.
2015-06-22 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (June 18, 2015). The content focuses entirely on reporting the NAV per share (856.22p) and mentions treasury shares in relation to NAV. This directly matches the definition for Net Asset Value updates.
2015-06-19 English
THE BIOTECH GROWTH TRUST PLC - Net Asset Value(s)
Net Asset Value Classification · 1% confidence The document explicitly states it is providing the 'Net Asset Value(s)' for 'THE BIOTECH GROWTH TRUST PLC' as of a specific date (June 17, 2015). The content focuses entirely on reporting the NAV figure (841.45p) and related treasury share information, which directly matches the definition for Net Asset Value updates, primarily associated with investment funds.
2015-06-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.